ILAE-Latin America

The ILAE - Latin America region comprises South and Middle America and Mexico where Spanish and Portuguese are the main languages spoken. Within the framework and according to the strategic plan of the central ILAE, the goal of the ILAE-Latin America is to serve as a regional resource for current and emerging knowledge on epilepsy prevention, diagnosis, treatment, and research.

Current efforts of the ILAE-Latin America are focused on the development of national epilepsy programs and laws and telemedicine projects in the region. In the field of education, courses are being organized for the primary health level as well as specialized epilepsy care.

As the region is extremely heterogeneous, an effort is being made to provide equal learning opportunities for health professionals in rich and poor countries and areas. Guidelines and seminal scientific articles that are available only in English are being translated into Spanish and Portuguese to increase access to knowledge.

Latest News

ILAE logo
About ILAE

Announcing Neurobiology Commission Bursaries

New funding opportunity for young trainees and investigators with limited financial resources to attend scientific meetings, workshops or other training opportunities that promise to advance their research career. The bursaries will cover travel expenses to a maximum of $2,000 per applicant to attend a scientific or training activity.

2 April, 2019
Sheryl Haut & Jaideep Kapur
About ILAE

Apply now for ILAE Leadership Development Program Scholarship

The Leadership Development Program is a unique and exclusive opportunity to receive leadership training and network with leaders from around the globe. Session topics include: The Science of Communication, Strategic Planning, Conflict Resolution & Negotiation, Finance, Management Essentials, Assessing and Leveraging Your Leadership Style, Opportunities to Lead within ILAE, and more.

The Lancet Neurology
World News

Global, regional, and national burden of epilepsy, 1990-2016

Despite the decrease in the disease burden from 1990 to 2016, epilepsy is still an important cause of disability and mortality. Standardised collection of data on epilepsy in population representative surveys will strengthen the estimates, particularly in countries for which we currently have no or sparse data...

18 February, 2019

View All Commission News